Related Experiment Videos
Optimization of 125I ophthalmic plaque brachytherapy
M A Astrahan1, G Luxton, G Jozsef
1Department of Radiation Oncology, University of Southern California School of Medicine, Los Angeles 90033.
Medical Physics
|November 1, 1990
Summary
Optimizing ophthalmic plaque brachytherapy for ocular melanoma can reduce radiation retinopathy. Computer modeling shows adjusting source parameters can improve the tumor apex to macula dose ratio, potentially preserving vision.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Medical Physics
Background:
- Episcleral plaques with 125I sources are standard for ocular melanoma treatment.
- Radiation retinopathy causing visual loss is a common complication within four years post-treatment.
Purpose of the Study:
- To optimize ophthalmic plaque therapy to minimize vision-limiting complications.
- To improve patient outcomes by reducing radiation retinopathy incidence without compromising tumor control.
Main Methods:
- Development of a three-dimensional computer model for ophthalmic plaque therapy simulations.
- Exploration of optimization strategies by modifying source location, activity distribution, orientation, and shielding.
- Analysis of the dose ratio to the tumor apex (T) versus the macula (M).
Main Results:
- A T:M ratio variation by a factor of 2 was achieved for a common plaque design and posterior tumor location.
- Optimization strategies did not significantly alter tumor margins or dose to the tumor volume.
- Maximizing the T:M ratio emerged as a promising optimization strategy.
Conclusions:
- Computer modeling allows exploration of ophthalmic plaque therapy optimization strategies.
- Modifying plaque parameters can significantly alter the dose distribution, specifically the T:M ratio.
- This approach holds potential for reducing radiation retinopathy and improving visual outcomes in ocular melanoma patients.